Publication | Closed Access

Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma

Rheumatoid DisorderRheumatologyAutoimmune DiseaseRheumatic DiseasesImmunologyClinical TrialsInflammatory Rheumatic DiseaseRecombinant Interferon-gammaMedicineRheumatoid Arthritis